| 3F3V | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 1BU BindingDB | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc., Getlik M, Grutter C, Simard JR, Kluter S, Rabiller M, Rode HB, Robubi A, Rauh D, J Med Chem. 2009 Jul 9;52(13):3915-26. PMID:19462975 | ||||||||||||||
| Data retrieval |
![]() |
| View 3F3V in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |